Jay L. Johnson
Analyst · Carter Copeland from Barclays
Okay. The latter first. As I said, we're fairly confident -- well, let me back up. The ECP1, as it is called, which I alluded to in my remarks, the long-term Abrams R&D contract, was very important to lock down, if you will, the long view on the Abrams. So we'll be working that on the engineering development side as we approach the 2017 time frame. But in the interim, as I said, it's really important to keep that facility in the industrial base intact, if you will. The 2012 budget supports Abrams through 2013, and what we believe will come out of the 2013 budget will push that out, at least, another year. That's kind of -- so are we taking it a year at a time in this instance? Absolutely. But we're all sight-lining to the 2017 longer view. So we're confident with the support we have, and so that will work itself out here in the coming months, okay? In addition to that, and recall I believe we've talked about this before, but we have international work that also will reside at that facility with the Moroccan tanks, which we expect the order by the end of the year or shortly thereafter, and we've got the Israel Namer Merkava hulls. We've got the Egyptian kits. So we've got a number of international programs that work through that facility as well. So our view is that, that we're getting the requisite support we need, and we'll do everything we can to keep that facility very functional for, as we've discussed many times, it's actually more about the supply chain than it is about General Dynamics with the 560-some suppliers that are tied to the Lima facility that we cannot afford to lose. So that, I think, perhaps answers the tank. The Vangent beneficiary call center, I believe I'm correct here, and Amy nods her head, that this will take place now next year. So we continue to work, we continue to execute, but the contract recompete will be at some point in 2013, which is a change. They pushed it out, but we continue to work since we're the incumbent.